Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandra Latini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 73 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

HIV MDR is still a relevant issue despite its dramatic drop over the years

Armenia, D., Di Carlo, D., Flandre, P., Bouba, Y., Borghi, V., Forbici, F., Bertoli, A., Gori, C., Fabeni, L., Gennari, W., Pinnetti, C., Mondi, A., Cicalini, S., Gagliardini, R., Vergori, A., Bellagamba, R., Malagnino, V., Montella, F., Colafigli, M., Latini, A. & 8 others, Marocco, R., Licthner, M., Andreoni, M., Mussini, C., Ceccherini-Silberstein, F., Antinori, A., Perno, C. F. & Santoro, M. M., May 1 2020, In : The Journal of antimicrobial chemotherapy. 75, 5, p. 1301-1310 10 p.

Research output: Contribution to journalArticle

  • Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)

    Ciccullo, A., Baldin, G., Capetti, A., Borghi, V., Sterrantino, G., Latini, A., Madeddu, G., Celani, L., Vignale, F., Rossetti, B., Dusina, A., Cossu, M. V., Restelli, S., Gennari, W., Lagi, F., Giacomelli, A., Colafigli, M., Brescini, L., Borghetti, A., Mussini, C. & 2 others, Rusconi, S. & Di Giambenedetto, S., Dec 2 2019, In : BMJ Open. 9, 12, p. e029960

    Research output: Contribution to journalArticle

  • Open Access
  • Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

    Sgadari, C., Monini, P., Tripiciano, A., Picconi, O., Casabianca, A., Orlandi, C., Moretti, S., Francavilla, V., Arancio, A., Paniccia, G., Campagna, M., Bellino, S., Meschiari, M., Nozza, S., Sighinolfi, L., Latini, A., Muscatello, A., Saracino, A., Di Pietro, M., Galli, M. & 4 others, Cafaro, A., Magnani, M., Ensoli, F. & Ensoli, B., 2019, In : Frontiers in Immunology. 10

    Research output: Contribution to journalArticle

  • Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study

    Baldin, G., Ciccullo, A., Capetti, A., Rusconi, S., Sterrantino, G., Cossu, M. V., Giacomelli, A., Lagi, F., Latini, A., Bagella, P., De Luca, A., Di Giambenedetto, S. & Madeddu, G., 2019, In : HIV Medicine. 20, 2, p. 164-168 5 p.

    Research output: Contribution to journalArticle